Table 1. Baseline characteristics by degree of polypharmacy.
Characteristic+ | No polypharmacy (n = 738,923,785) | Minor polypharmacy (n = 341,779,401) | Moderate polypharmacy (n = 256,247,011) | Major polypharmacy (n = 779,309,084) |
---|---|---|---|---|
Age (years), median (IQR) | 74 (69–80) | 73 (68–79) | 73 (68–80) | 75 (70–81) |
Female sex, % | 55.5 | 57.5 | 56.1 | 57.5 |
Race, % | ||||
White | 66.2 | 62.5 | 66.0 | 67.2 |
Black/African American | 5.7 | 6.0 | 7.2 | 6.4 |
Other | 4.3 | 4.7 | 4.0 | 2.9 |
More than one race | 0.1 | 0.1 | 0.2 | 0.2 |
Hispanic or Latino ethnicity, % | 7.1 | 7.7 | 7.9 | 6.1 |
Chronic conditions, median (IQR) | 0 (1–2) | 2 (1–3) | 2 (1–3) | 3 (2–4) |
+ All comparisons between no polypharmacy vs. minor polypharmacy vs. moderate polypharmacy vs. major polypharmacy groups were deemed statistically significant if p<0.0001